Gender differences in obesity related cardiovascular risk factors in Spain

Preventive Medicine

Volumn 48, Issue 2, 2009, Pages 134-139

  Cordero, Alberto ^a   León, Montse ^b   Andrés, Eva ^b   Ordoñez, Beatriz ^b   Laclaustra, Martín ^c   Grima, Alberto ^d   Pascual, Isaac ^b   Luengo, Emilio ^b   Civeira, Fernando ^b   Pocoví, Miguel ^b   Alegría, Eduardo ^e   Casasnovas, José A ^b  

^a HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^c CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^d Asepeyo ^*  (Spain)

^e UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Gender differences; Obesity; Overweight; Risk factors

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN;

ARTICLE; ATHEROGENESIS; BODY MASS; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; SEX DIFFERENCE; SPAIN;

EID: 59649121743     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2008.10.024     Document Type: Article

References (42)

1. Adult Treatment Panel III. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
2. Alegria E., Cordero A., Laclaustra M., Grima A., Leon M., Casasnovas J.A., Luengo E., Del Rio A., et al. Prevalence of metabolic syndrome in the Spanish working population: MESYAS registry. Rev. Esp. Cardiol. 58 (2005) 797-806
3. Arca M., Montali A., Valiante S., Campagna F., Pigna G., Paoletti V., Antonini R., Barilla F., et al. Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery disease. Am. J. Cardiol. 100 (2007) 1511-1516
4. Ascaso J.F., Romero P., Real J.T., Lorente R.I., Marti nez-Valls J., and Carmena R. Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population. Eur. J. Intern. Med. 14 (2003) 101-106
5. Bonora E., Kiechl S., Willeit J., Oberhollenzer F., Egger G., Meigs J.B., Bonadonna R.C., and Muggeo M. Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study. Diabetes 53 (2004) 1782-1789
6. Carnethon M.R., Gidding S.S., Nehgme R., Sidney S., Jacobs D.R., and Liu K. Cardiorespiratory fitness in young adulthood and the development of cardiovascular disease risk factors. JAMA 290 (2003) 3092-3100
7. Chan J.L., Bluher S., Yiannakouris N., Suchard M.A., Kratzsch J., and Mantzoros C.S. Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: observational and interventional studies in humans. Diabetes 51 (2002) 2105-2112
8. Cheal K.L., Abbasi F., Lamendola C., McLaughlin T., Reaven G.M., and Ford E.S. Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes 53 (2004) 1195-1200
9. Cordero A., Laclaustra M., Leon M., Casasnovas J.A., Grima A., Najar M., Luengo E., del R.A., et al. Cardiovascular risk factors and metabolic syndrome associated with subclinical renal failure. Med. Clin. (Barc) 125 (2005) 653-658
10. Cordero A., Laclaustra M., Leon M., Grima A., Casasnovas J.A., Luengo E., Del Rio A., Ferreira I., et al. Prehypertension is associated with insulin resistance state and not with an initial renal function impairment. A Metabolic Syndrome in Active Subjects in Spain (MESYAS) registry substudy. Am. J. Hypertens 19 (2006) 189-196
11. Cordero A., Laclaustra M., Leon M., Casasnovas J.A., Grima A., Luengo E., Ordonez B., Bergua C., et al. Comparison of serum lipid values in subjects with and without the metabolic syndrome. Am. J. Cardiol. 102 (2008) 424-428
12. Fontaine K.R., Redden D.T., Wang C., Westfall A.O., and Allison D.B. Years of life lost due to obesity. JAMA 289 (2003) 187-193
13. Galassi A., Reynolds K., and He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am. J. Med. 119 (2006) 812-819
14. Gami A.S., Witt B.J., Howard D.E., Erwin P.J., Gami L.A., Somers V.K., and Montori V.M. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J. Am. Coll. Cardiol. 49 (2007) 403-414
15. Haffner S.M., Mykkanen L., Festa A., Burke J.P., and Stern M.P. Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state. Circulation 101 (2000) 975-980
16. Hanak V., Munoz J., Teague J., Stanley A., and Bittner V. Accuracy of the triglyceride to high-density lipoprotein cholesterol ratio for prediction of the low-density lipoprotein phenotype B. Am. J. Cardiol. 94 (2004) 219-222
17. Hossain P., Kawar B., and El N.M. Obesity and diabetes in the developing world-a growing challenge. N. Engl. J. Med. 356 (2007) 213-215
18. Howard B.V., Cowan L.D., Go O., Welty T.K., Robbins D.C., and Lee E.T. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study. Diabetes Care 21 (1998) 1258-1265
19. Hu G., Qiao Q., Tuomilehto J., Balkau B., Borch-Johnsen K., and Pyorala K. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch. Intern. Med. 164 (2004) 1066-1076
20. Hulthe J., Bokemark L., Wikstrand J., and Fagerberg B. The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) study. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2140-2147
21. Kumanyika S.K., Obarzanek E., Stettler N., Bell R., Field A.E., Fortmann S.P., Franklin B.A., Gillman M.W., et al. Population-based prevention of obesity: the need for comprehensive promotion of healthful eating, physical activity, and energy balance: a scientific statement from American heart association council on epidemiology and prevention, interdisciplinary committee for prevention (formerly the expert panel on population and prevention science). Circulation 118 (2008) 428-464
22. Lakoski S.G., Cushman M., Criqui M., Rundek T., Blumenthal R.S., D'Agostino Jr. R.B., and Herrington D.M. Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am. Heart J. 152 (2006) 593-598
23. Lemieux I., Lamarche B., Couillard C., Pascot A., Cantin B., Bergeron J., Dagenais G.R., and Despres J.P. Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. Arch. Intern. Med. 161 (2001) 2685-2692
24. Levantesi G., Macchia A., Marfisi R., Franzosi M.G., Maggioni A.P., Nicolosi G.L., Schweiger C., Tavazzi L., et al. Metabolic syndrome and risk of cardiovascular events after myocardial infarction. J. Am. Coll. Cardiol. 46 (2005) 277-283
25. Lloyd-Jones D.D., Liu K., Colangelo L.A., Yan L.L., Klein L., Loria C.M., Lewis C.E., and Savage P. Consistently stable or decreased body mass index in young adulthood and longitudinal changes in metabolic syndrome. The Coronary Artery Risk Development in young adults study. Circulation 115 (2007) 1004-1011
26. Lutsey P.L., Steffen L.M., and Stevens J. Dietary intake and the development of the metabolic syndrome: the Atherosclerosis Risk in Communities study. Circulation 117 (2008) 754-761
27. McLaughlin T., Abbasi F., Cheal K., Chu J., Lamendola C., and Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann. Intern. Med. 139 (2003) 802-809
28. Mosca L., Banka C.L., Benjamin E.J., Berra K., Bushnell C., Dolor R.J., Ganiats T.G., Gomes A.S., et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 115 (2007) 1481-1501
29. Panagiotakos D.B., Pitsavos C., Arvaniti F., and Stefanadis C. Adherence to the Mediterranean food pattern predicts the prevalence of hypertension, hypercholesterolemia, diabetes and obesity, among healthy adults; the accuracy of the MedDietScore. Prev. Med. 44 (2007) 335-340
30. Peytremann-Bridevaux I., Faeh D., and Santos-Eggimann B. Prevalence of overweight and obesity in rural and urban settings of 10 European countries. Prev. Med. 44 (2007) 442-446
31. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
32. Ridker P.M., Buring J.E., Cook N.R., and Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107 (2003) 391-397
33. Rosengren A., Wilhelmsen L., Lappas G., and Johansson S. Body mass index, coronary heart disease and stroke in Swedish women. A prospective 19-year follow-up in the BEDA study. Eur. J. Cardiovasc. Prev. Rehabil. 10 (2003) 443-450
34. Sattar N., Gaw A., Scherbakova O., Ford I., O'Reilly D.S., Haffner S.M., Isles C., Macfarlane P.W., et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108 (2003) 414-419
35. Schillaci G., Pirro M., Vaudo G., Gemelli F., Marchesi S., Porcellati C., and Mannarino E. Prognostic value of the metabolic syndrome in essential hypertension. J. Am. Coll. Cardiol. 43 (2004) 1817-1822
36. Stramba-Badiale M., Fox K.M., Priori S.G., Collins P., Daly C., Graham I., Jonsson B., Schenck-Gustafsson K., et al. Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology. Eur. Heart J. 27 (2006) 994-1005
37. Tofler G.H., Massaro J., Levy D., Mittleman M., Sutherland P., Lipinska I., Muller J.E., and D'Agostino R.B. Relation of the prothrombotic state to increasing age (from the Framingham Offspring Study). Am. J. Cardiol. 96 (2005) 1280-1283
38. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
39. Wilson P.W., D'Agostino R.B., Sullivan L., Parise H., and Kannel W.B. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch. Intern. Med. 162 (2002) 1867-1872
40. Wilson P.W., D'Agostino R.B., Parise H., Sullivan L., and Meigs J.B. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112 (2005) 3066-3072
41. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., McQueen M., Budaj A., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004) 937-952
42. Zhang C., Rexrode K.M., van Dam R.M., Li T.Y., and Hu F.B. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation 117 (2008) 1658-1667